NDC 0054-0413 – Febuxostat
Febuxostat 40 mg/1 · Tablet · Oral
Product NDC0054-0413
Product details
- Brand name
- Febuxostat
- Generic name
- Febuxostat
- Labeler
- Hikma Pharmaceuticals USA Inc
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA205414
- Marketed since
- November 11, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Xanthine Oxidase Inhibitor
Active ingredients
- Febuxostat 40 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0054-0413-13 | 30 TABLET in 1 BOTTLE (0054-0413-13) | Nov 11, 2019 |
Other Febuxostat products
- 71610-450 Febuxostat 40 mg/1 · Tablet · Aphena Pharma Solutions - Tennessee, LLC
- 59651-113 Febuxostat 40 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-114 Febuxostat 80 mg/1 · Tablet · Aurobindo Pharma Limited
- 55111-797 Febuxostat 80 mg/1 · Tablet · DR REDDY'S LABORATORIES LIMITED
- 55111-796 Febuxostat 40 mg/1 · Tablet · DR REDDY'S LABORATORIES LIMITED
- 51407-293 Febuxostat 40 mg/1 · Tablet · Golden State Medical Supply, Inc.
- 51407-294 Febuxostat 80 mg/1 · Tablet · Golden State Medical Supply, Inc.
- 72303-0856 Febuxostat 80 mg/1 · Tablet · HEC Pharm USA Inc.
- 72303-0855 Febuxostat 40 mg/1 · Tablet · HEC Pharm USA Inc.
- 0054-0414 Febuxostat 80 mg/1 · Tablet · Hikma Pharmaceuticals USA Inc
- 0527-2244 Febuxostat 40 mg/1 · Tablet · Lannett Company, Inc.
- 0527-2248 Febuxostat 80 mg/1 · Tablet · Lannett Company, Inc.